Mork Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Mork Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$1.62M	–	108
2025 Q4	$1.62M	Hold	30,000	–	–	0.99%	31
2025 Q3	$1.35M	Hold	30,000	–	–	0.93%	40
2025 Q2	$1.39M	Hold	30,000	–	–	1.01%	30
2025 Q1	$1.83M	Hold	30,000	–	–	1.43%	14
2024 Q4	$1.7M	Hold	30,000	–	–	1.12%	21
2024 Q3	$1.55M	Hold	30,000	–	–	1.11%	27
2024 Q2	$1.25M	Hold	30,000	–	–	0.98%	35
2024 Q1	$1.63M	Hold	30,000	–	–	1.23%	20
2023 Q4	$1.54M	Hold	30,000	–	–	0.95%	24
2023 Q3	$1.74M	Hold	30,000	–	–	1.36%	16
2023 Q2	$1.92M	Hold	30,000	–	–	1.47%	12
2023 Q1	$2.08M	Hold	30,000	–	–	1.69%	5
2022 Q4	$2.16M	Hold	30,000	–	–	1.66%	3
2022 Q3	$2.13M	Hold	30,000	–	–	2.09%	2
2022 Q2	$2.31M	Hold	30,000	–	–	2.12%	2
2022 Q1	$2.19M	Hold	30,000	–	–	1.98%	4
2021 Q4	$1.87M	Hold	30,000	–	–	1.27%	15
2021 Q3	$1.77M	Hold	30,000	–	–	1.51%	20
2021 Q2	$2M	Hold	30,000	–	–	1.45%	22
2021 Q1	$1.89M	Hold	30,000	–	–	1.44%	22
2020 Q4	$1.86M	Hold	30,000	–	–	1.36%	16
2020 Q3	$1.81M	Hold	30,000	–	–	1.98%	7
2020 Q2	$1.76M	Hold	30,000	–	–	2.07%	6
2020 Q1	$1.67M	Hold	30,000	–	–	2.29%	3
2019 Q4	$1.93M	Hold	30,000	–	–	1.38%	10
2019 Q3	$1.52M	Hold	30,000	–	–	1.39%	15
2019 Q2	$1.36M	Hold	30,000	–	–	1.26%	26
2019 Q1	$1.43M	Buy	+30,000	New	+$1.49M	1.33%	22

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mork Capital Management's BMY Position: Q1 2026 in Review

Mork Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 30,000 shares — an estimated $1.62M sold.

Mork Capital Management first reported a position in BMY in Q1 2019 and held it in 28 quarters. The position peaked at $2.31M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Mork Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Mork Capital Management sold 30,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.62M.
Mork Capital Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 28 quarters.
Mork Capital Management's Bristol-Myers Squibb position peaked at $2.31M in Q2 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mork Capital Management's 13F filing for Q1 2026, filed 15 May 2026.